Format

Send to

Choose Destination
Thorac Surg Clin. 2017 May;27(2):149-157. doi: 10.1016/j.thorsurg.2017.01.008.

Management of Lung Cancer Invading the Superior Sulcus.

Author information

1
Department of Thoracic Surgery, University of California, San Francisco, Box 0118, San Francisco, CA 94143-0118, USA. Electronic address: johannes.kratz@ucsf.edu.
2
Department of Surgery, University of California, San Francisco, Box 0470, 513 Parnassus Avenue, 321, San Francisco, CA 94122, USA.
3
Department of Thoracic Surgery, University of California, San Francisco, 1600 Divisadero Street, Room A-743, San Francisco, CA 94143-1724, USA.

Abstract

Superior sulcus tumors have posed a formidable therapeutic challenge since their original description by Pancoast and Tobias in the early twentieth century. Initial therapeutic efforts with radiotherapy were associated with high rates of relapse and mortality. Bimodality therapy with complete surgical resection in the 1960s paved the way for trimodality therapy as the current standard of care in the treatment of superior sulcus tumors. The evolution of treatment approaches over time has provided outcomes that come increasingly closer to rivaling those of similarly staged nonapical lung cancer.

KEYWORDS:

Apical; Non–small cell lung cancer; Pancoast; Superior sulcus; Tumor

PMID:
28363369
DOI:
10.1016/j.thorsurg.2017.01.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center